Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
50.2% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
3.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
6
users have liked this narrative
1
users have commented on this narrative
15
users have followed this narrative
7 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
1.4% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
52.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Dana
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Operational Efficiency And Electrification Will Power Long-Term Success
Key Takeaways Enhanced operational efficiency and disciplined capital allocation are set to boost profitability, free cash flow, and shareholder returns. Strategic focus on electrification and new mobility programs aligns Dana with industry trends, supporting long-term sales growth and margin expansion.
View narrative
US$23.71
FV
21.9% undervalued
intrinsic discount
-6.41%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
4 days ago
author updated this narrative
Howard Hughes Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Sunbelt Migration And Quality Land Will Unlock Lasting Value
Key Takeaways Strong demand for master-planned communities and undeveloped land holdings supports resilience, revenue growth, and long-term value appreciation. Increased recurring income, operational efficiency initiatives, and strategic diversification efforts are expected to drive higher margins and earnings stability.
View narrative
US$80.25
FV
8.7% undervalued
intrinsic discount
7.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
18
users have followed this narrative
4 days ago
author updated this narrative
dentalcorp Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Acquisitions And Digital Workflows Will Underpin Canadian Dental Care
Key Takeaways Growing patient volumes, operational efficiencies, and expanded services are driving higher margins, cash flow, and sustainable earnings growth. Aggressive acquisition strategy leverages low market penetration, supporting national expansion and further profitability without increasing financial risk.
View narrative
CA$12.66
FV
35.8% undervalued
intrinsic discount
8.64%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
Fluence
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Water Scarcity Trends And US Manufacturing Will Test Future Outlook
Key Takeaways Overreliance on non-recurring project revenues and modest order growth outside major deals risk disappointing future earnings and inflated growth expectations. Persistent regulatory, logistical, and macroeconomic headwinds could delay projects, inflate costs, and cap margin expansion relative to current market valuation.
View narrative
AU$0.0018
FV
3.5k% overvalued
intrinsic discount
22.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
Lendlease Group
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Restructuring And Divestment Will Refocus International Operations
Key Takeaways Cost reduction and divestment efforts may enhance net margins and focus on high-margin core operations. Growth through development ventures and increased funds under management could boost future revenue and earnings.
View narrative
AU$6.59
FV
15.4% undervalued
intrinsic discount
-7.94%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
4 days ago
author updated this narrative
Venus Pipes and Tubes
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
New Capacity And Exports Will Fuel Robust Infrastructure Demand
Key Takeaways Capacity expansion into value-added products and automation are set to boost margins, operational efficiency, and position Venus for long-term, sustainable profit growth. Growing export footprint and leadership in organized, high-grade domestic segments reduce risk, enable market share gains, and ensure robust sales momentum.
View narrative
₹1.92k
FV
30.5% undervalued
intrinsic discount
24.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
4 days ago
author updated this narrative
Apellis Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
FDA Label Expansion And SYFOVRE Will Unlock Future Value
Key Takeaways Expansion into rare kidney diseases and strong leadership in eye disease treatments set the stage for revenue growth and increased market reach. Enhanced balance sheet and operational efficiency enable greater investment in R&D and commercialization, supporting profitability and long-term earnings potential.
View narrative
US$37.74
FV
27.5% undervalued
intrinsic discount
18.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
4 days ago
author updated this narrative
National Atomic Company Kazatomprom JSC
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
Global Nuclear Expansion Will Unlock Enduring Uranium Value
Key Takeaways Strong global uranium demand and supply deficits strengthen Kazatomprom's long-term pricing power, revenue growth, and earnings stability. Ongoing investment and downstream expansion support low-cost leadership and create new, higher-margin revenue streams.
View narrative
US$52.73
FV
16.3% undervalued
intrinsic discount
14.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
27
users have followed this narrative
4 days ago
author updated this narrative
Penguin Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
AI And Digital Transformation Will Drive Global Data Center Success
Key Takeaways Strong growth is supported by increasing AI-driven demand, expanding services, and key partnerships that enhance product innovation and earnings stability. Customizable, energy-efficient solutions and a broadening sales pipeline position the company to gain additional market share and improve profitability.
View narrative
US$27.13
FV
8.9% undervalued
intrinsic discount
10.36%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies